Literature DB >> 30917630

Cell Death and Liver Disease.

Satoka Aizawa1, Gurmehr Brar1, Hidekazu Tsukamoto1,2.   

Abstract

Cell death is now reclassified into several types based on the mechanisms and morphologic phenotype. Understanding of such classifications offers insights into the pathogenesis of liver disease, as well as diagnostic or therapeutic implications. Apoptosis is recognized relatively easily due to its unique morphology, but lytic cell death may occur in the form of accidental necrosis, mitochondria permeability transition-driven necrosis, necroptosis, pyroptosis, ferroptosis, and parthanatos. The cell may be engulfed by neighboring cells due to a loss of integrin signaling or cancer cell competition by entosis, a type of cell death. The classification also includes mechanistically termed cell death such as autophagy-dependent cell death and lysosome-dependent cell death. These different types of cell death may occur uniquely in certain liver diseases but may coexist in the evolution of the disease. They occur in parenchymal and non-parenchymal liver cells, as well as inflammatory cells, causing distinct pathologic consequences. This review briefly covers the recently revised classifications of cell death and discusses their relevance to liver diseases of different etiologies.

Entities:  

Keywords:  Apoptosis; Ferroptosis; Mitochondria permeability transition-driven necrosis; Necroptosis; Pyroptosis

Year:  2020        PMID: 30917630     DOI: 10.5009/gnl18486

Source DB:  PubMed          Journal:  Gut Liver        ISSN: 1976-2283            Impact factor:   4.519


  16 in total

Review 1.  Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy.

Authors:  Amir Ajoolabady; Daolin Tang; Guido Kroemer; Jun Ren
Journal:  Br J Cancer       Date:  2022-10-13       Impact factor: 9.075

Review 2.  Molecular Mechanisms of Parthanatos and Its Role in Diverse Diseases.

Authors:  Ping Huang; Guangwei Chen; Weifeng Jin; Kunjun Mao; Haitong Wan; Yu He
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

3.  Hepatic Oxidative Stress, Apoptosis, and Inflammation in Broiler Chickens With Wooden Breast Myopathy.

Authors:  Tong Xing; Xiaona Pan; Lin Zhang; Feng Gao
Journal:  Front Physiol       Date:  2021-04-14       Impact factor: 4.566

Review 4.  The Potential Application of Magnetic Nanoparticles for Liver Fibrosis Theranostics.

Authors:  Aziz Eftekhari; Allahveirdy Arjmand; Ayyub Asheghvatan; Helena Švajdlenková; Ondrej Šauša; Huseyn Abiyev; Elham Ahmadian; Oleh Smutok; Rovshan Khalilov; Taras Kavetskyy; Magali Cucchiarini
Journal:  Front Chem       Date:  2021-05-14       Impact factor: 5.221

Review 5.  Necroptosis in Cholangiocarcinoma.

Authors:  Samantha Sarcognato; Iris E M de Jong; Luca Fabris; Massimiliano Cadamuro; Maria Guido
Journal:  Cells       Date:  2020-04-15       Impact factor: 6.600

6.  M2-like macrophages exert hepatoprotection in acute-on-chronic liver failure through inhibiting necroptosis-S100A9-necroinflammation axis.

Authors:  Li Bai; Ming Kong; Zhongping Duan; Shuang Liu; Sujun Zheng; Yu Chen
Journal:  Cell Death Dis       Date:  2021-01-18       Impact factor: 8.469

Review 7.  Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure.

Authors:  Mireia Casulleras; Ingrid W Zhang; Cristina López-Vicario; Joan Clària
Journal:  Cells       Date:  2020-12-08       Impact factor: 6.600

Review 8.  Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy.

Authors:  Alejandra Hernández; Juan Pablo Arab; Daniela Reyes; Ainhoa Lapitz; Han Moshage; Jesús M Bañales; Marco Arrese
Journal:  Cells       Date:  2020-03-27       Impact factor: 6.600

Review 9.  Necroptosis in Intestinal Inflammation and Cancer: New Concepts and Therapeutic Perspectives.

Authors:  Anna Negroni; Eleonora Colantoni; Salvatore Cucchiara; Laura Stronati
Journal:  Biomolecules       Date:  2020-10-10

Review 10.  Cell-in-Cell Structures in the Liver: A Tale of Four E's.

Authors:  Scott P Davies; Lauren V Terry; Alex L Wilkinson; Zania Stamataki
Journal:  Front Immunol       Date:  2020-05-13       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.